Dzau
Victor Dzau, Newton, MA US
Patent application number | Description | Published |
---|---|---|
20110044947 | METHODS OF TREATING CARDIAC DISORDERS - The invention feature methods and compositions for treating ischemic and reperfusuin related injury such as cardiac disorders. | 02-24-2011 |
Victor Dzau, Durham, NC US
Patent application number | Description | Published |
---|---|---|
20110003743 | STEM CELL DERIVED FACTORS FOR TREATING PATHOLOGIC CONDITIONS - A purified paracrine factor of a mesenchymal stem cell, such as a Secreted frizzled related protein (Sfrp) is useful to reduce cell death an/or tissue injury associated with ischemic condtions. | 01-06-2011 |
20120283183 | METHOD OF REDUCING CELL DEATH BY ADMINISTERING A PARACRINE FACTOR OF A MESENCHYMAL STEM CELL - A purified paracrine factor of a mesenchymal stem cell, such as a Secreted frizzled related protein (Sfrp) is useful to reduce cell death an/or tissue injury associated with ischemic condtions. | 11-08-2012 |
Victor J. Dzau, Newton, MA US
Patent application number | Description | Published |
---|---|---|
20110091430 | MESENCHYMAL STEM CELLS AND METHODS OF USE THEREOF - The invention provides compositions and methods of enhancing the viability of primary stem cells and enhancing the engraftment of transplanted stem cells into a mammalian recipient. Accordingly, the invention includes a method of regenerating a mesenchymally-derived tissue by contacting the tissue with a composition containing an isolated adult mesenchymal stem cell, which are apoptosis-resistant. The mesenchymal stem cell is an adult cell obtained from an adult bone marrow. | 04-21-2011 |
Victor J. Dzau, Durham, NC US
Patent application number | Description | Published |
---|---|---|
20110071086 | COMPOSITIONS FOR TISSUE REPAIR/REGENERATION - The invention provides compositions and methods for cardiac repair and/or regeneration of tissues such as myocardium. | 03-24-2011 |
20120172306 | Use of HASF as a Protective Agent Against Ischemic Tissue Damage - A method of inducing a protective response against ischemic tissue damage is carried out by administering to subject a composition comprising an HASF polypeptide. The composition is administered prior to an ischemic event such as myocardial infarction to reduce tissue damage associated with such an event. | 07-05-2012 |
20140011281 | Direct Reprogramming of Cells to Cardiac Myocyte Fate - A method for promoting conversion of cells into cardiomyocytic tissue is carried out by contacting fibrotic tissue (e.g., scar tissue) with a microRNA oligonucleotide or combination of microRNA oligonucleotides. The methods lead to direct reprogramming of fibroblasts to cardiomyocytes or cardiomyoblasts. | 01-09-2014 |
20140296152 | Stem Cell Derived Factors for Treating Pathologic Conditions - A purified paracrine factor of a mesenchymal stem cell, such as a Secreted frizzled related protein (Sfrp) is useful to reduce cell death an/or tissue injury associated with ischemic conditions. | 10-02-2014 |
20140357703 | Stem Cell Derived Factors for Treating Pathologic Conditions - A purified paracrine factor of a mesenchymal stem cell, such as a Secreted frizzled related protein (Sfrp) is useful to reduce cell death an/or tissue injury associated with ischemic conditions. | 12-04-2014 |